Trial Profile
Pharmacokinetic and pharmacodynamic interactions of apixaban and naproxen in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Naproxen
- Indications Acute coronary syndromes; Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 03 Dec 2015 New trial record